RESUMO
L-lactic acidosis (L-LA) is the most common cause of metabolic acidosis in the critical care setting, which has been associated with a large increase in mortality. The purpose of this article is to provide clinicians with an overview of the biochemical and metabolic background required to understand the different pathophysiological mechanisms that may lead to the development of L-LA. We propose a classification based on whether the pathophysiology of L-LA is due predominantly to increased production or decreased removal of L-lactic acid. In this article, we provide an overview of the biochemical and metabolic aspects of glucose oxidation, the production and removal of L-lactic acid, and a discussion of the pathophysiology of the various causes of L-LA.
Assuntos
Acidose Láctica/etiologia , Bicarbonatos/metabolismo , Hipóxia/etiologia , Ácido Láctico/metabolismo , Acidose Láctica/sangue , Acidose Láctica/diagnóstico , Acidose Láctica/mortalidade , Ânions/sangue , Ânions/metabolismo , Bicarbonatos/sangue , Ciclo do Ácido Cítrico/fisiologia , Estado Terminal , Complexo de Proteínas da Cadeia de Transporte de Elétrons/metabolismo , Gluconeogênese/fisiologia , Glucose/metabolismo , Glicólise/fisiologia , Mortalidade Hospitalar , Humanos , Concentração de Íons de Hidrogênio , Hipóxia/sangue , Hipóxia/diagnóstico , Hipóxia/mortalidade , Unidades de Terapia Intensiva/estatística & dados numéricos , Rim/metabolismo , Rim/fisiologia , Ácido Láctico/sangue , Fígado/metabolismo , Fígado/fisiopatologia , Músculo Esquelético/metabolismo , Oxirredução , Fosforilação Oxidativa , Oxigênio/metabolismoRESUMO
We summarize the current understanding of the physiology of the renal handling of potassium (K+), and present an integrative view of the renal response to K+ depletion caused by dietary K+ restriction. This renal response involves contributions from different nephron segments, and aims to diminish the rate of excretion of K+ as a result of: decreasing the rate of electrogenic (and increasing the rate of electroneutral) reabsorption of sodium in the aldosterone-sensitive distal nephron (ASDN), decreasing the abundance of renal outer medullary K+ channels in the luminal membrane of principal cells in the ASDN, decreasing the flow rate in the ASDN, and increasing the reabsorption of K+ in the cortical and medullary collecting ducts. The implications of this physiology for the association between K+ depletion and hypertension, and K+ depletion and formation of calcium kidney stones are discussed.
Assuntos
Néfrons/metabolismo , Deficiência de Potássio/urina , Potássio na Dieta/urina , Eliminação Renal , Reabsorção Renal , Adaptação Fisiológica , Animais , Humanos , Hipertensão/fisiopatologia , Hipertensão/urina , Cálculos Renais/fisiopatologia , Cálculos Renais/urina , Néfrons/fisiopatologia , Deficiência de Potássio/fisiopatologiaAssuntos
Antidiuréticos/uso terapêutico , Desamino Arginina Vasopressina/uso terapêutico , Diabetes Insípido/diagnóstico , Hipernatremia/tratamento farmacológico , Complicações Pós-Operatórias/tratamento farmacológico , Adulto , Diabetes Insípido/complicações , Diabetes Insípido/tratamento farmacológico , Humanos , Hipernatremia/etiologia , Masculino , Solução Salina Hipertônica/efeitos adversos , Sódio/sangueRESUMO
Diabetic ketoacidosis (DKA), a common cause of severe metabolic acidosis, remains a life-threatening condition due to complications of both the disease and its treatment. This Acid-Base and Electrolyte Teaching Case discusses DKA management, emphasizing complications of treatment. Because cerebral edema is the most common cause of mortality and morbidity, especially in children with DKA, we emphasize its pathophysiology and implications for therapy. The risk for cerebral edema may be minimized by avoiding a bolus of insulin, excessive saline resuscitation, and a decrease in effective plasma osmolality early in treatment. A goal of fluid therapy is to lower muscle venous Pco2 to ensure effective removal of hydrogen ions by bicarbonate buffer in muscle and diminish the binding of hydrogen ions to intracellular proteins in vital organs (such as the brain). In patients with DKA and a relatively low plasma potassium level, insulin administration may cause hypokalemia and cardiac arrhythmias. It is suggested in these cases to temporarily delay insulin administration and first administer potassium chloride intravenously to bring the plasma potassium level close to 4mmol/L. Sodium bicarbonate administration in adult patients should be individualized. We suggest it be considered in a subset of patients with moderately severe acidemia (pH<7.20 and plasma bicarbonate level < 12mmol/L) who are at risk for worsening acidemia, particularly if hemodynamically unstable. Sodium bicarbonate should not be administered to children with DKA, except if acidemia is very severe and hemodynamic instability is refractory to saline administration.
Assuntos
Cetoacidose Diabética/tratamento farmacológico , Adolescente , Humanos , Masculino , Cloreto de Potássio/uso terapêutico , Bicarbonato de Sódio/uso terapêuticoRESUMO
Our purpose is to integrate new insights in potassium (K(+)) physiology to understand K(+) homeostasis and illustrate some of their clinical implications. Since control mechanisms that are essential for survival were likely developed in Paleolithic times, we think the physiology of K(+) homeostasis can be better revealed when viewed from what was required to avoid threats and achieve balance in Paleolithic times. Three issues will be highlighted. First, we shall consider the integrative physiology of the gastrointestinal tract and the role of lactic acid released from enterocytes following absorption of sugars (fruit and berries) to cause a shift of this K(+) load into the liver. Second, we shall discuss the integrative physiology of WNK kinases and modulation of delivery of bicarbonate to the distal nephron to switch the aldosterone response from sodium chloride retention to K(+) secretion when faced with a K(+) load. Third, we shall emphasize the role of intra-renal recycling of urea in achieving K(+) homeostasis when the diet contains protein and K(+).
Assuntos
Homeostase/fisiologia , Nefropatias/dietoterapia , Potássio na Dieta/administração & dosagem , Humanos , Potássio/metabolismoAssuntos
Equilíbrio Ácido-Base/fisiologia , Edema Encefálico/etiologia , Cetoacidose Diabética/tratamento farmacológico , Cetoacidose Diabética/metabolismo , Bicarbonato de Sódio/uso terapêutico , Bicarbonatos/sangue , Criança , Cetoacidose Diabética/complicações , Ácidos Graxos/metabolismo , Humanos , Mitocôndrias/metabolismo , Concentração Osmolar , Oxirredução , Bicarbonato de Sódio/efeitos adversos , Bicarbonato de Sódio/metabolismoRESUMO
International guidelines designed to minimize the risk of complications that can occur when correcting severe hyponatremia have been widely accepted for a decade. On the basis of the results of a recent large retrospective study of patients hospitalized with hyponatremia, it has been suggested that hyponatremia guidelines have gone too far in limiting the rate of rise of the serum sodium concentration; the need for therapeutic caution and frequent monitoring of the serum sodium concentration has been questioned. These assertions are reminiscent of a controversy that began many years ago. After reviewing the history of that controversy, the evidence supporting the guidelines, and the validity of data challenging them, we conclude that current safeguards should not be abandoned. To do so would be akin to discarding your umbrella because you remained dry in a rainstorm. The authors of this review, who represent 20 medical centers in nine countries, have all contributed significantly to the literature on the subject. We urge clinicians to continue to treat severe hyponatremia cautiously and to wait for better evidence before adopting less stringent therapeutic limits.
RESUMO
BACKGROUND/AIMS: Since furosemide (FS) inhibits active Na(+) reabsorption by medullary thick ascending limb (mTAL) in the renal outer medulla, it may decrease its work during periods of low O2 supply to deep in the renal outer medulla. This study was designed to demonstrate that there may be a dose of FS would reduce its metabolic work while preventing the excessive loss of magnesium (Mg(2+)). Mg(2+) is important because the ATP needed to perform work must have bound Mg(2+) to it. METHODS: Rats were injected intraperitoneally with a range of doses of FS. The measured outcomes were urine flow rate and parameters of functions of the mTAL (i.e. urine and renal papillary osmolality and urinary excretion of Na(+), Cl(-), K(+) and Mg(2+), and concentrations of Mg(2+) in serum). RESULTS: The urine flow rate increased significantly starting at 2.4 mg FS/kg. The renal papillary osmolality decreased at ≥0.4 mg FS/kg, and the large detectable natriuresis started at 1.6 mg FS/kg. At this latter dose, the urinary excretion of Mg(2+) rose significantly. CONCLUSION: In rats, the non-natriuretic dose of FS may reduce the work of the mTAL. The earliest indicator of reduced work in the mTAL appears to be a decrease in urine osmolality rather than a rise in urine flow rate. Higher doses of FS should be avoided, as they induce high rates of Mg(2+) excretion, which can deplete the body of this essential electrolyte.
Assuntos
Furosemida/farmacologia , Medula Renal/efeitos dos fármacos , Magnésio/urina , Animais , Cloretos/urina , Diuréticos/administração & dosagem , Diuréticos/farmacologia , Relação Dose-Resposta a Droga , Furosemida/administração & dosagem , Injeções Intraperitoneais , Medula Renal/fisiologia , Magnésio/sangue , Masculino , Natriurese/efeitos dos fármacos , Concentração Osmolar , Potássio/urina , Ratos , Ratos Sprague-Dawley , Sódio/urina , Urina/química , Urodinâmica/efeitos dos fármacosRESUMO
PURPOSE OF REVIEW: This review aims to illustrate why urea recycling may play an important role in potassium (Kâº) excretion and to emphasize its potential clinical implications. RECENT FINDINGS: A quantitative analysis of the process of intrarenal urea recycling reveals that the amount of urea delivered to the distal convoluted tubule is about two-fold larger than the quantity of urea excreted in the urine. As the number of osmoles delivered to the late cortical distal nephron (CCD) determines its flow rate when aquaporin 2 water channels have been inserted in the luminal membrane of principal cells, urea recycling may play an important role in regulating the rate of excretion of K⺠when the distal delivery of electrolytes is not very high. SUMMARY: Urea recycling aids the excretion of Kâº; this is especially important in patients with disorders or those who are taking drugs that lead to a less lumen-negative voltage in the CCD. As a large quantity of urea is reabsorbed daily in the inner medullary collecting duct, the assumption made in the calculation of the transtubular K concentration gradient that there is no appreciable reabsorption of osmoles downstream CCD is not valid.
Assuntos
Rim/metabolismo , Potássio/metabolismo , Ureia/metabolismo , Animais , Homeostase , Humanos , Hiperpotassemia/metabolismo , Hiperpotassemia/fisiopatologia , Rim/fisiopatologia , Equilíbrio HidroeletrolíticoRESUMO
We discuss the use of urine electrolytes and urine osmolality in the clinical diagnosis of patients with fluid, electrolytes, and acid-base disorders, emphasizing their physiological basis, their utility, and the caveats and limitations in their use. While our focus is on information obtained from measurements in the urine, clinical diagnosis in these patients must integrate information obtained from the history, the physical examination, and other laboratory data.
RESUMO
Two processes permit the urine pH and the medullary interstitial pH to remain in an "ideal range" to minimize the risk of forming kidney stones. First, a medullary shunt for NH(3) maintains the urine pH near 6.0 to minimize uric acid precipitation when distal H(+) secretion is high. Second, excreting dietary alkali excreting alkali as a family of organic anions--including citrate--rather than as bicarbonate maintains the urine pH near 6.0 while urinary citrate chelates ionized calcium, which minimizes CaHPO(4) precipitation. In patients with idiopathic hypercalciuria and recurrent calcium oxalate stones, the initial nidus is a calcium phosphate precipitate on the basolateral membrane of the thin limb of the loop of Henle (Randall's plaque). Formation of this precipitate requires medullary alkalinization; K(+) -depletion and augmented medullary H(+)/K(+) -ATPase may be predisposing factors.
Assuntos
Equilíbrio Ácido-Base/fisiologia , Cálculos Renais/prevenção & controle , Cálculos Renais/urina , Cálcio/urina , Oxalato de Cálcio/urina , Fosfatos de Cálcio/urina , Ácido Cítrico/urina , Progressão da Doença , Humanos , Concentração de Íons de Hidrogênio , Medula Renal/metabolismo , Prognóstico , Ácido Úrico/urinaAssuntos
Doenças Desmielinizantes/prevenção & controle , Hiponatremia/tratamento farmacológico , Minociclina/farmacologia , Animais , Doença Crônica , Doenças Desmielinizantes/etiologia , Modelos Animais de Doenças , Humanos , Hiponatremia/complicações , Pressão Osmótica , Ratos , Sódio/sangue , Fatores de TempoAssuntos
Acidose/diagnóstico , Acidose/metabolismo , Doenças Metabólicas/diagnóstico , Doenças Metabólicas/metabolismo , Ânions/urina , Bicarbonatos/sangue , Volume Sanguíneo , Dióxido de Carbono/sangue , Líquido Extracelular/metabolismo , Hematócrito , Humanos , Concentração de Íons de Hidrogênio , Compostos de Amônio Quaternário/urinaRESUMO
BACKGROUND AND OBJECTIVES: Hyperkalemia is a common electrolyte disorder that can result in fatal cardiac arrhythmias. Despite the importance of insulin as a lifesaving intervention in the treatment of hyperkalemia in an emergency setting, there is no consensus on the dose or the method (bolus or infusion) of its administration. Our aim was to review data in the literature to determine the optimal dose and route of administration of insulin in the management of emergency hyperkalemia. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We searched several databases from their date of inception through February 2015 for eligible articles published in any language. We included any study that reported on the use of insulin in the management of hyperkalemia. RESULTS: We identified eleven studies. In seven studies, 10 units of regular insulin was administered (bolus in five studies, infusion in two studies), in one study 12 units of regular insulin was infused over 30 minutes, and in three studies 20 units of regular insulin was infused over 60 minutes. The majority of included studies were biased. There was no statistically significant difference in mean decrease in serum potassium (K+) concentration at 60 minutes between studies in which insulin was administered as an infusion of 20 units over 60 minutes and studies in which 10 units of insulin was administered as a bolus (0.79±0.25 mmol/L versus 0.78±0.25 mmol/L, P = 0.98) or studies in which 10 units of insulin was administered as an infusion (0.79±0.25 mmol/L versus 0.39±0.09 mmol/L, P = 0.1). Almost one fifth of the study population experienced an episode of hypoglycemia. CONCLUSION: The limited data available in the literature shows no statistically significant difference between the different regimens of insulin used to acutely lower serum K+ concentration. Accordingly, 10 units of short acting insulin given intravenously may be used in cases of hyperkalemia. Alternatively, 20 units of short acting insulin may be given as a continuous intravenous infusion over 60 minutes in patients with severe hyperkalemia (i.e., serum K+ concentration > 6.5 mmol/L) and those with marked EKG changes related to hyperkalemia (e.g., prolonged PR interval, wide QRS complex) as an alternative to 10 units of short acting insulin. Because the risk of hypoglycemia is increased with using large insulin doses, sufficient glucose (60 grams with the administration of 20 units of insulin and 50 grams with the administration of 10 units) should be given to prevent hypoglycemia, and plasma glucose should be frequently monitored.